Article Text

Download PDFPDF

Highlights from this issue
Free
  1. The Triumvirate

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

As we write this month’s Airwaves citizens, scientists and politicians around the world are preparing for a second wave of COVID-19 cases while hoping their fears are groundless. This month’s airwaves takes the “second wave” as its theme and we explore reappearances and recurrences - both welcome and unwelcome. We bring you chimpanzees, off-target effects and dental extractions.

Chimpanzees, RSV and CEACAM3

As the nights draw in and the months of November, December and January approach, every paediatrician knows that the season for respiratory syncytial virus (RSV) is approaching. RSV, originally named “chimpanzee coryza agent”, causes regular winter epidemics, resulting in the hospitalisation of around 2% of infants with acute bronchiolitis as well as episodes of wheezing in older children. One of the enduring puzzles of RSV is why some children have a more severe respiratory illness than others. In this month’s Thorax, Tsai and colleagues (see page 725) describe a meta-analysis to investigate differentially expressed genes (DEGs) of RSV infection from Gene Expression Omnibus (GEO) datasets. Using their findings from both a training and a validation dataset, the authors report that CEACAM3 mRNA expression is reduced in subjects experiencing asthma exacerbations. CEACAM3 (Carcinoembryonic antigen-related cell adhesion molecule 3) is an adhesion molecule …

View Full Text